OpenBilldrug price receipt

NADAC week of 2026-10-14

ALFUZOSIN HCL ER 10 MG TABLET

For 30 tablets

Pharmacies pay

$3.15 filed

30 × $0.10513 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$8.96 filed

30 × $0.29857 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.8× estimated

Medicare paid 2.8× what pharmacies pay.

Part D averages every strength and form sold under “Alfuzosin HCl ER” / “Alfuzosin HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$8.62 estimated

$3.15 + $0.47 (15%) + $5.00 fee per fill = $8.62

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ALFUZOSIN HCL ER 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as alfuzosin hydrochloride.

FDA gives its dosage form as “tablet, extended release” and “tablet, film coated, extended release” and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Unichem Pharmaceuticals (USA), Inc., Rising Pharma Holdings, Inc. and Apotex Corp.

FDA’s Established Pharmacologic Class for it is alpha-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 9 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.15 for 30 tablets (30 × $0.10513 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 4 labelers

LabelerNDCsPharmacies pay per unit
Exelan Pharmaceuticals Inc.5$0.10513 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.10513 per EA filed
Apotex Corp.1$0.10513 per EA filed
Rising Pharma Holdings, Inc.1$0.10513 per EA filed
All 9 NDCs, with labeler and price
  • 29300-0155-01 · Unichem Pharmaceuticals (USA), Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 29300-0155-19 · Unichem Pharmaceuticals (USA), Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 57237-0114-90 · Rising Pharma Holdings, Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 60505-2850-09 · Apotex Corp. · $0.10513 per EA · eff. 2026-09-23 filed
  • 76282-0302-01 · Exelan Pharmaceuticals Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 76282-0302-05 · Exelan Pharmaceuticals Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 76282-0302-10 · Exelan Pharmaceuticals Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 76282-0302-12 · Exelan Pharmaceuticals Inc. · $0.10513 per EA · eff. 2026-09-23 filed
  • 76282-0302-90 · Exelan Pharmaceuticals Inc. · $0.10513 per EA · eff. 2026-09-23 filed

Compared with its class

The middle of its 9 NDCs’ NADAC prices is $0.10513 per EA filed.

Of the 24 other products in FDA’s alpha-Adrenergic Blocker class priced per EA, 13 have a higher middle NADAC price and 11 a lower one. The one in the middle is TERAZOSIN 2 MG CAPSULE, at $0.10551 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $8.96 for 30 tablets, at an average of $0.29857 per EA in 2024 (2024-01-01 to 2024-12-31) for “Alfuzosin HCl ER” and “Alfuzosin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,095,800 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ALFUZOSIN HCL ER 10 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Alfuzosin HCl ER / Alfuzosin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.